The Moving Average Convergence Divergence (MACD) for CDMO turned positive on August 19, 2024. Looking at past instances where CDMO's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Engages in the developing and manufacturing of monoclonal antibody therapeutics
Industry Biotechnology